Clinical Trials
3 trialsNCT02771340 2020-10-01
Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Iconic Therapeutics, Inc.
Phase 1 Completed
NCT00406120 2018-06-26
Validation of a Molecular Prognostic Test for Eye Melanoma
Washington University School of Medicine
Withdrawn
NCT00000124 2006-06-02
Collaborative Ocular Melanoma Study (COMS)
National Eye Institute (NEI)
Phase 3 Unknown